(Q58022800)

English

Jacalin-capped silver nanoparticles minimize the dosage use of the anticancer drug, shikonin derivatives, against human chronic myeloid leukemia

scholarly article in RSC Advances, vol. 6 no. 23, 2016

Statements

Jacalin-capped silver nanoparticles minimize the dosage use of the anticancer drug, shikonin derivatives, against human chronic myeloid leukemia (English)
0 references
Khan Behlol Ayaz Ahmed
0 references
Santanu Kar Mahapatra
0 references
Mamilla R. Charan Raja
0 references
Shankar Subramaniam
0 references
Megarajan Sengan
0 references
Narendran Rajendran
0 references
Sandeep Kumar Das
0 references
Kuntal Haldar
0 references
Somenath Roy
0 references
Aravind Sivasubramanian
0 references
Veerappan Anbazhagan
0 references
2016
0 references
0 references
6
0 references
23
0 references
18980-18989
0 references

Identifiers

0 references
 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit